Cystic Fibrosis

March 21, 2016May 13, 2016

Lung Infections in Cystic Fibrosis Found From Airborne Bacteria Triggering Fungal Growth

Cystic Fibrosis, News

According to new research, volatile compounds released by a bacterial pathogen called Pseudomonas aeruginosa can trigger the growth of a fungal pathogen often found in cystic fibrosis (CF) patients. This is ... Read more

March 18, 2016March 18, 2016

Verona Pharma Reports Positive Early Trial Data for its CF, COPD Lead Drug Candidate

Cystic Fibrosis, News

Verona Pharma recently announced positive top-line results from a Phase 2a dose-finding clinical trial using its novel lead drug nebulized formulation of RPL554, a first-in-class inhaled drug under development for ... Read more

March 16, 2016March 16, 2016

Viral Infections May Affect Cystic Fibrosis Patients’ Respiratory Microbiome, Study Says

Cystic Fibrosis, News

Viral infections in patients with cystic fibrosis (CF) have been linked to pulmonary exacerbations, according to the results of a study recently presented at the American Academy of Allergy, Asthma & ... Read more

March 14, 2016March 16, 2016

RespirTech Introduces Cystic Fibrosis Treatment Remote Monitoring System

Bronchiectasis, COPD, Cystic Fibrosis, News

RespirTech, an important provider of airway clearance therapy vests, is developing an innovative way for clinicians to remotely monitor the treatment of cystic fibrosis (CF) patients, funded by a Small Business Innovation Research (SBIR) ... Read more

March 10, 2016March 16, 2016

Nivalis Expands Clinical Development of Its Cystic Fibrosis CFTR Stabilizer

Cystic Fibrosis, News

Nivalis Therapeutics recently announced the expansion of the clinical development plan for N91115, the company’s investigational, first-in-class stabilizer of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, which is defective in ... Read more

March 10, 2016March 16, 2016

Cystic Fibrosis Foundation Receives doTERRA Donation for Fundraising Banquet in North Carolina

Cystic Fibrosis, News

The Cystic Fibrosis Foundation‘s Sixth Annual STANDOUT Awards banquet, held in North Carolina, recognized business men and women in the Charlotte community and raise money for the Foundation. At the event, ... Read more

March 9, 2016March 16, 2016

Better Lives for Cystic Fibrosis Patients Is Focus of £750,000 Grant for Physical Activity, Exercise Programs

Cystic Fibrosis, News

A renowned team of international specialists at the University of Exeter in England was awarded a grant of £750,000 from the Cystic Fibrosis Trust to develop an inclusive strategy to allow young people who ... Read more

March 8, 2016March 8, 2016

New Research into Cystic Fibrosis Lung Infections Could Pave Way to Better Treatments

Cystic Fibrosis, News

Recent research progress into how bacteria adapt and evolve in chronic lung infections in cystic fibrosis patients could lead to the development of improved treatment strategies, according to a new review ... Read more

March 7, 2016March 16, 2016

Savara Preparing Clinical Trial on Lung Infection Therapy for CF After Completing $20M Round of Financing

Cystic Fibrosis, News

Austin, Texas-based Savara Pharmaceuticals, a company focused on novel drugs for the treatment of rare respiratory diseases, recently announced the completion of a $20 million Series C round of financing. The ... Read more

March 3, 2016March 16, 2016

Vertex Awards $1M in Grants to 18 Nonprofits for Cystic Fibrosis Initiatives

Cystic Fibrosis, News

Vertex Pharmaceuticals recently awarded the company’s 2016 Cystic Fibrosis (CF) Circle of Care grants to 18 medical, academic, and community organizations, totaling nearly $1 million. Now in its second year, the CF Circle of ... Read more